James Samuel Shannon, Director at Horizon Therapeutics Public Ltd Co (HZNP), sold 25,000 shares at $26.59 ($661K) on 2019-09-12, disclosed to the SEC on 2019-09-13.
Open-market sale of $661k HZNP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.59 | 15,500 | $412K | 62.4% |
| 2 | $26.19 | 9,500 | $249K | 37.6% |
| Total | $26.44 avg | 25,000 | $661K | 100% |
| Filing → |
| HZNP | SELL | 2021-03-03 | $1.3M | — | Filing → |